remains challenging. Here we describe a platform used to identify and modify genetically tractable mammalian microbiota by engineering community-wide horizontal gene transfer events in situ. With this approach, we demonstrate that diverse taxa in the mouse gut microbiome can be modified directly with a desired genetic payload. In situ microbiome engineering in living animals allows novel capabilities to be introduced into established communities in their native milieu.
recipients or transconjugants, which could then be readily isolated on antibiotic selective plates. This multi-pronged strategy can increase the diversity of genetically tractable microbiota that can be captured. We first validated and optimized MAGIC protocols in vitro by assessing the gating stringency of FACS with control spike-ins of GFP-tagged bacteria into a complex sample community ( Supplementary Fig. 2 ). Subsequently, in vitro conjugations with defined recipient species ( Supplementary Fig. 3 ) and live bacterial communities extracted from mouse feces ( Supplementary  Fig. 4 ) demonstrated the transfer of the payload from donors to recipients to yield GFP + transconjugants that could be enriched by FACS ( Supplementary Fig. 5 ), which we confirmed by fluorescence microscopy ( Supplementary Fig. 6 ). 16S rRNA sequencing of FACS-enriched transconjugant populations revealed a diverse range of recipient bacteria ( Supplementary Fig. 7 ).
Metagenomic engineering of the mammalian gut microbiome in situ
Carlotta Ronda 1,5 , Sway P. Chen 1,2,5 , Vitor Cabral 1,5 , Stephanie J. Yaung 3 . MAGIC implementation to transfer replicative or integrative pGT vectors from an engineered donor strain into amenable recipients in a complex microbiome. Replicative vectors feature a broadhost-range origin of replication (oriR), whereas integrative vectors contain a transposable Himar cassette and transposase (Tnase). The donor E. coli strain contains genomically integrated conjugative transfer genes (tra) and an mCherry gene (mCh). Transconjugant bacteria are detectable on the basis of expression of an engineered payload that includes GFP and an antibiotic-resistance gene (AbR).
Next, we explored the possibility of implementing MAGIC in vivo, directly in the native gut microbiome of an animal. We hypothesized that different groups of microbiota could be modified through the use of a library of pGT vectors with a range of gene expression levels and plasmid replication elements suitable for different gut bacteria. We generated libraries of pGT vectors (pGT-L1 to pGT-L6) by modularly permuting pGT parts, including regulatory sequences of varying activity, payload-selectable genes (bla, catP, tetQ), transposon elements (Himar), and plasmid origins (RSF1010, pBBR1, p15A) ( Supplementary Tables 1 and 2 ). We carried out four separate in vivo studies in which EcGT2 donors containing pGT libraries were orally gavaged into conventionally raised C57BL/6J mice obtained from commercial vendors ( Supplementary  Fig. 8a ). To assess the transfer capacity of individual pGT replicative or integrative designs (pBBR1, p15A-Himar, and RSF1010), we introduced the pGT libraries pGT-L1, pGT-L2, and pGT-L3 Flavobacteriaceae(1)_Capnocytophaga (1) Flavobacteriaceae (1) (1) Corynebacteriaceae (1)_Corynebacterium (1) Corynebacteriaceae (1)_Corynebacterium (1) Corynebacteriaceae (1)_Corynebacterium (1) Veillonellaceae(1)_Selenomonas(.79)
Veillonellaceae (1)_Veillonella (1) Streptococcaceae (1)_Lactococcus (1) Streptococcaceae (1)_Streptococcus (1) Streptococcaceae (1)_Streptococcus (1) Streptococcaceae (1) pGT-L3 transconjugants, tetracycline selection Each heat map column represents transconjugants from one mouse. The relative abundance of each operational taxonomic unit (OTU) in the total bacterial population is shown in the grayscale heat map, and each OTU's fold enrichment among transconjugants is shown in the orange heat map. In the table on the right, numbers in parentheses indicate the confidence of taxonomic assignment by RDP Classifier. Genera with successfully cultivated isolates are denoted by white stars. d, PCR confirmed the presence of the antibiotic resistance-GFP payload cassette from pGT-L3 and pGT-L6 vectors in diverse isolates that were engineered in the mouse gut and isolated by selective plating with carbenicillin or tetracycline. "NA" indicates 16S sequences that were not available.
separately into a cohort of mice from Taconic ( Supplementary  Fig. 8b -d). We tested larger combinatorial libraries (pGT-L3 to pGT-L6) in two independent mouse cohorts to assess variability across cohorts ( Fig. 2 , Supplementary Fig. 9 ). To compare in situ transfer in different gut communities, we tested the pGT-L6 library in mice from a different source (Charles River) ( Supplementary Fig. 10 ). We carried out FACS enrichment and 16S metagenomic analysis on fecal material from all mice studied, collected over time after oral gavage with pGT libraries. Across in situ studies, up to 5% of resulting bacteria seemed to be successful transconjugants (i.e., GFP + mCherry -) 6 h post-gavage, compared with those in samples from control groups (mice gavaged with PBS or EcGT2 carrying a nontransferable vector, pGT-NT) ( Fig. 2a and Supplementary  Figs. 8b, 9a , and 10a). These GFP + mCherrytransconjugants persisted for up to 72 h post-gavage ( Fig. 2b, Supplementary Fig. 9b ). 16S metagenomic sequencing of these transconjugant populations revealed a wide phylogenetic breadth ( Fig. 2c and Supplementary Figs. 8c, 9c, and 10b). We observed substantial reproducible enrichment of Proteobacteria and Firmicutes, especially Clostridiales and Bacillales, among successful transconjugants across multiple independent experiments. Use of the same pGT-L6 library in mice from different vendors, which harbored distinct microbiomes ( Supplementary Fig. 10c ), yielded shared and distinct transconjugants ( Supplementary Fig. 10d ). In parallel to FACS metagenomic studies, we isolated individual transconjugants from these fecal samples by selective plating for the payload AbR, and confirmed the presence of the GFP-AbR payload by PCR ( Fig. 2d ). Across all experiments, we isolated and validated more than 297 transconjugants belonging to 19 genera across 4 phyla ( Supplementary  Fig. 11 , Supplementary Table 4 ), thus validating the capacity of MAGIC to broadly transfer genetic material in situ to diverse recipients in the mammalian gut. In contrast, we could isolate only seven genera from in vitro conjugation experiments using the same pGT vectors, despite a similar diversity of transconjugants detected by FACS metagenomics ( Supplementary Fig. 7) . This difference may be due to in vitro conditions that suboptimally support the growth of diverse species during conjugation reactions, which underscores the value of implementing MAGIC in situ in an established complex microbiome.
As transconjugants were no longer detected by 72 h in situ ( Fig. 2b, Supplementary Fig. 9b ), we speculated that the genetic payload on pGT vectors might be unstable or toxic, thus causing its negative selection in transconjugants. We tested this hypothesis in vitro by carrying out 20-30 serial passages of two transconjugant isolates of Escherichia fergusonii that contained the GFP-carbenicillin resistance (carbR) payload on either a pGT-B1 (replicative pBBR1 origin) or a pGT-Ah1 (integrative Himar transposon) plasmid ( Supplementary Fig. 12 ). For the pGT-B1 population, we observed a considerable decrease in the fraction of GFP + cells ( Supplementary Fig. 12a -c). PCR assay of the origin of replication indicated that the pGT-B1 plasmid was no longer present in the GFPcells ( Supplementary Fig. 12d ). In contrast, cells in the pGT-Ah1 population remained GFP + despite a detectable loss of the plasmid in parts of the population over time ( Supplementary  Fig. 12e -g), which suggests a more stable maintenance of the GFP-carbR payload as an integrative transposon within the host genome. Together, these results highlight the challenges of maintaining the long-term in vivo stability of engineered genetic constructs in complex microbial communities, and suggest design considerations for more precise tuning of payload life span and improved payload biocontainment.
Whole-genome sequencing of three transconjugant strains of Proteus mirabilis and E. fergusonii from our studies (designated as modifiable gut bacteria MGB3, MGB4, and MBG9) revealed the presence of putative endogenous DNA mobilization systems ( Supplementary Fig. 13a -c). We wondered whether these native Lactobacillaceae (1)_Lactobacillus (1) Streptococcaceae (1)_Streptococcus (1) Bacillaceae (1) Pseudomonadaceae (1)_Pseudomonas (1) Xanthomonadaceae (1)_Stenotrophomonas (1) Sinobacteraceae (1)_Nevskia (1) Porphyromonadaceae(.93)_Barnesiella(.55)
Prevotellaceae (1)_Prevotella (1) Campylobacteraceae (1) mobilization systems could interface with our engineered pGT vectors, and thus carried out in vitro conjugations of the MGB strains with laboratory E. coli recipients. We discovered that MGB4 and MGB9 (both E. fergusonii) were able to mobilize pGT vectors into recipients, although less efficiently than our engineered EcGT2 donor ( Fig. 3a, Supplementary Fig. 13d ). These results suggest that some native gut bacteria can promote secondary transfer of engineered payloads by using their endogenous conjugation machinery, which may improve payload transfer in situ.
In general, non-gut-adapted bacteria (e.g., probiotics) do not colonize an established gut microbiome. Infiltration of foreign species usually requires drastic perturbations, such as the use of broad-spectrum antibiotics to suppress the natural flora. Even then, exogenous species do not persist after discontinuation of antibiotic suppression 11 . As our donor strains did not readily colonize the mouse gut and transconjugants were lost soon after ( Fig. 2b, Supplementary Figs. 9b and 14a ), we reasoned that using a colonizing donor strain might extend the persistence of payload constructs in situ. To explore this possibility, we tested whether a mixed population of MGB strains (MGB3, MGB4, and MGB9) could stably recolonize the native mouse gut after a single oral dose without any antibiotic coadministration ( Supplementary  Fig. 15a ). In contrast to the rapid disappearance of a non-gutadapted strain (EcGT1) within 48 h, MGB strains (especially MGB4) recolonized the mouse gut and stably persisted for at least 15 d ( Fig. 3b, Supplementary Fig. 15b ), populating the entire gastrointestinal tract ( Supplementary Fig. 15c ). FACS enrichment and 16S sequencing of GFP-expressing bacteria in feces from these mice revealed transconjugants resulting from in situ transfer of the pGT payload from MGB strains to the native microbiome 6 h ( Fig. 3c ) and 11 d post-gavage ( Supplementary Fig. 15d ). These transconjugant populations had similar phylogeny but less diversity than those from prior in situ experiments using the noncolonizing EcGT2 donor ( Fig. 2c, Supplementary Fig. 9c ). These results highlight the utility of MAGIC for the isolation of host-derived engineerable strains that can be modified and then used to stably recolonize the native community and mediate further transfer of engineered functions in situ.
In summary, MAGIC enables metagenomic infiltration of genetic payloads into a native microbiome, and isolation of genetically modifiable strains from diverse communities. These strains can be reintroduced into their original community to maintain engineered functions via sustained vertical and horizontal transmission in situ. Future improvements to the system, such as optimization of vector stability and donor-strain dosage ( Supplementary  Fig. 14b ), could allow for better quantitative and temporal control of retention of genetic payloads in situ, which might be useful in applications requiring short-term or long-term actuation of engineered functions [12] [13] [14] . Designing genetic programs based on recipientspecific properties should enhance the targeted execution of desired functions in a defined subset of species in a community 15, 16 . MAGIC and complementary strategies to engineer the horizontal gene pool can facilitate programmable execution of genetic circuits in other microbial communities [17] [18] [19] [20] . The isolation of genetically tractable representatives from diverse microbiomes will expand the repertoire of new microbial chassis for emerging applications in synthetic biology and microbial ecology.
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Isolation of live mouse gut bacteria. Fresh fecal pellets were collected from mice, and live gut bacteria were isolated by mechanical homogenization. Briefly, 250 µ l of PBS was added to previously weighed pellets in a microcentrifuge tube. Pellets were thoroughly mechanically disrupted with a motorized pellet pestle, and then 750 µ l of PBS was added. The disrupted pellets in PBS were then subjected to four iterations of vortex mixing for 15 s at medium speed, centrifugation at 1,000 r.p.m. for 30 s at room temperature, recovery of 750 µ l of supernatant in a new tube, and replacement of that volume of PBS before the next iteration. The resulting 3 ml of isolated cells were pelleted by centrifugation at 4,000g for 5 min at room temperature, the supernatant was discarded, and cells were resuspended in 0.5-1.0 ml of PBS. All gut bacteria isolations were performed in an anaerobic chamber (Coy Labs).
Donor strain construction.
We derived donor strains EcGT1 and EcGT2 from the S17 λ pir E. coli strain 21 by generating modifications Δ galK::mCherry-specR and Δ asd::mCherry-specR, respectively, with λ -red recombineering using the pKD46 system 22 . Synthetic cassettes containing constitutively active mCherry and specresistance genes were constructed with ~40 bp of homology on both ends to galK or asd flanking regions on the E. coli genome. 100 ng of mCherry-specR cassette DNA were electroporated into recombineering-competent S17-pKD46 cells. Cells were allowed to recover in 3 ml of LB media plus carb at 30 °C for 3 h before being plated on LB media plus spec. Spec-resistant colonies were genotyped by PCR for validation of mutations. The pKD46 recombineering plasmid was cured out of validated recombinants by growth at 37 °C in the absence of carb to yield the EcGT1 and EcGT2 strains used throughout the study. When generating the EcGT2 strain, we supplemented the growth media with DAP at all stages of the protocol.
Plasmid construction. pGT vectors were designed to have modular components (e.g., selectable markers, regulatory elements, replication origins) that are interchangeable by isothermal assembly (ITA) or Golden Gate assembly. Vector selection markers for E. coli were constitutively expressed, whereas the deliverable cargo and transposase cassettes were expressed using different regulatory elements to enable broad-host-range or narrow-host-range gene expression. The regulatory elements used in this study exhibit a range of activity ( Supplementary Table 1 ). Vector libraries used in this study are detailed in Supplementary Table 2 . Full vector component sequences are listed in Supplementary Table 3 . The nontransferable vector pGT-NT used as a negative control was a minimal p15A cloning vector with no origin of transfer, containing a constitutively expressed sfGFP gene.
All plasmids were constructed by ITA with NEBuilder HiFi DNA assembly master mix (New England Biolabs). Component parts were made by high-fidelity PCR with Q5 (NEB) or KAPA Hifi (Kapa Biosystems) polymerase, using existing vectors or gBlocks (Integrated DNA Technologies) as PCR templates. PCR products were digested with DpnI (NEB) and purified with the QIAquick PCR purification kit (Qiagen) before ITA and transformation into E. coli. All assembled plasmids were Sanger-sequence verified.
In vitro MAGIC studies on synthetic recipient community. Donor strains harboring pGT vectors and representative recipients (E. coli MG1655, S. enterica ATCC 700931, V. cholerae C9503, P. aeruginosa PA01, E. faecalis ATCC 29200, L. reuteri ATCC 23272, B. thetaiotaomicron ATCC 29148) were grown overnight in appropriate media and cultivation conditions, and a 1:1,000 dilution culture was regrown for 14 h at 37 °C before conjugation studies. To prepare cells for in vitro conjugation, we washed donor and recipient populations twice in PBS and quantified cells by OD 600 or flow cytometry using SYTO9 staining (Thermo Fisher). 10 8 donor cells and 10 8 recipient cells were mixed together, pelleted by centrifugation, and resuspended in 10 µ l of PBS. Donor and recipient mixes were spotted on an agar plate and incubated for 5 h at 30 °C or 37 °C for conjugation. In vitro conjugations were performed on LB-Lennox (E. coli, S. enterica, V. cholerae, P. aeruginosa, E. faecalis), MRS media (L. reuteri), or supplemented BHI agar (B. thetaiotaomicron). After conjugation, cells were scraped from the plate into 1 ml of PBS, and 100 µ l was plated on appropriate antibiotics and incubated overnight at 30 °C or 37 °C so we could determine the number of colony-forming units (CFUs) of transconjugants.
In vitro MAGIC studies on natural recipient community. Donor strains harboring pGT vectors were streaked onto LB-Lennox agar plates with appropriate antibiotics and supplements, grown at 37 °C overnight, and then grown from a single colony in 2 ml of liquid media for 10 h at 37 °C before conjugation. The recipient community was isolated anaerobically from fresh mouse feces as described above, immediately before conjugation. Donor cells were washed twice in PBS and quantified by OD 600 , whereas recipient cells were quantified by flow cytometry using SYTO9 staining. 10 8 donor cells and 10 9 recipient cells were mixed, pelleted by centrifugation at 5,000g, and resuspended in 25 µ l of PBS. The mixes were spotted on PBS + 1.5% agar plates and incubated at 37 °C either aerobically or anaerobically overnight (9-10 h). After conjugation, cells were scraped from the plate into 1 ml of PBS and subjected to antibiotic selection on GAM, FACS enrichment, and metagenomic 16S analysis (see below).
In vitro assessment of pGT vector horizontal gene transfer mediated by natural
isolates. MGB natural isolates harboring pGT vectors (MGB3, MGB9, and MBG4) were conjugated with a recipient E. coli strain harboring a kanamycinresistance plasmid compatible with pGT vectors. Prior to conjugations, all strains were streaked onto GAM agar plates with appropriate antibiotics, grown at 37 °C overnight, and then grown from a single colony in 5 ml of liquid GAM for 10 h at 37 °C before conjugation. MGB donor and recipient cells were washed twice in PBS and quantified by OD 600 . 10 9 cells each of MGB and recipient strains were mixed, pelleted by centrifugation at 5,000g, and resuspended in 15 µ l of PBS. The mixtures were spotted on GAM agar plates and incubated at 37 °C aerobically for 6 h. After conjugation, cells were scraped from the plate into 1 ml of PBS and plated on selective and nonselective GAM. Conjugation efficiency was calculated as t/n, where t is the number of E. coli transconjugant CFUs and n is the total number of E. coli CFUs.
Measurement of GFP expression in MGB strains. MGB isolates harboring
pGT vectors (MGB3, MGB9, MBG4) were streaked onto GAM agar plates with appropriate antibiotics, grown at 37 °C overnight, and then diluted to OD 600 0.001 in liquid GAM into a 96-well plate. The plate was incubated in a Synergy H1 (BioTek) microplate reader for 24 h at 37 °C with orbital shaking. Measurements of OD 600 and GFP expression (excitation, 488 nm; emission, 510 nm) were acquired with Gen5 software (BioTek) at the end of 24 h.
In vivo MAGIC studies in mice. Conventionally raised C57BL/6 female mice (Taconic Biosciences or Charles River Laboratories) were used throughout the study. Two control groups of four mice each were gavaged with PBS and EcGT2 containing a nontransferable GFP vector (pGT-NT). Three to four mice were used in each group gavaged with a pGT donor mix or with MGB strains. To equilibrate the mouse gut microbiome ahead of time, we mixed mice from multiple litters, cohoused them for at least 1 week before all experiments, and randomly allocated them into groups. Mice were gavaged with 10 9 donor cells (EcGT2 or MGB strains) in 300 µ l of PBS at 8-10 weeks old. Control mice were gavaged with 300 µ l of PBS. Fecal matter was collected immediately before gavage and periodically after gavage for analysis of the resulting microbiome populations by FACS, metagenomic 16S sequencing, and plating. Upon completion of the study, mice were euthanized, and small and large intestinal tissues were extracted. Luminal contents were washed from each tissue sample with PBS, and bacteria were extracted by homogenization of the luminal contents for plating and final CFU determination.
Flow cytometry and FACS measurements. Gut bacteria isolated from fresh fecal pellets were analyzed for evidence of successful conjugation on a flow cytometer (Guava easyCyte HT) using red (642 nm) and blue (488 nm) lasers with Red2 and Green photodiodes to detect mCherry (587/610 nm) and sfGFP (485/510 nm) fluorescence, respectively. Bacteria at 100× and 1,000× dilutions in PBS were used for optimal detection of donor material (GFP + mCherry + ), gut microbes without a transferred vector (GFP -mCherry -), and transconjugants (GFP + mCherry -). Data were collected and analyzed with InCyte 3.1 software. For FACS enrichment studies, a BD FACSAria II cell sorter operated with BD FACSDiva software was used to gate for sfGFP (FITC filter 515/10 nm) and mCherry (mCherry filter 616/26 nm). Double-gating on GFP and mCherry channels was used to select for cells with GFP + mCherryfluorescence. In addition, we took background events into account by using the GFP + mCherryfluorescence detected in the fecal sample before gavage as the baseline signal. An increase over the baseline signified an enrichment of transconjugants. Population density (cells per gram of fecal matter) was calculated as the number of cells sorted over the mass of the sorted fecal sample. Additional plating and direct colony counting were used to validate flow cytometry measurements. FACS plots were formatted with FCS Express 6.
Fluorescence microscopy of fecal bacteria. We suspended bacteria in PBS and centrifuged them at 5,000g to concentrate them into a smaller volume, which varied depending on the concentration of bacteria. The bacteria were resuspended by pipetting, and a volume of 15 µ l was dropped onto a Superfrost Plus microscope slide (Thermo Shandon) and covered with a glass coverslip. Slides were air-dried until the PBS receded from the edges of the coverslip and then were sealed with clear nail polish. Bacteria were imaged at 40× magnification on a Nikon Eclipse Ti2 microscope on bright-field, RFP, and GFP channels using NIS-Elements-AR software.
Validation of pGT vectors in transconjugants.
Transconjugant validation was done by colony PCR of the GFP-antibiotic resistance payload and/or the pGT vector backbone. PCR products with the expected size were further verified by Sanger sequencing. Taxonomy assignment of isolated colonies was based on 16S rRNA PCR amplification and Sanger sequencing. All transconjugant strains validated in the study are listed in Supplementary Table 4 .
In vitro evolution of transconjugant gut bacteria. E. fergusonii transconjugants MGB4 and MGB9 were serially passaged in LB media for 11-15 d. Starting from a single colony, the strains were inoculated into LB and grown at 37 °C with shaking. Every 12 h the liquid culture was diluted 1:1,000 into fresh LB media. At selected time points an aliquot of the saturated culture was plated on selective (50 µ g/ml carb) and nonselective plates for quantification of the percentage of cells expressing the payload antibiotic-resistance and GFP genes. MGB9 cultures were also plated on selective plates with 20 µ g/ml chloramphenicol to check for maintenance of the plasmid backbone.
Metagenomic 16S sequencing. Genomic DNA was extracted from isolated bacteria populations with the MasterPure Gram-positive DNA purification kit (Epicentre). PCR amplification of the 16S rRNA V4 region and multiplexed barcoding of samples were done in accordance with previous protocols 23 . The V4 region of the 16S rRNA gene was amplified with customized primers according to the method described by Kozich et al. 23 , with the following modifications: (i) alteration of 16S primers to match updated EMP 505f and 806rB primers [24] [25] [26] and (ii) use of NexteraXT indices such that each index pair was separated by a Hamming distance of > 2 and Illumina low-plex pooling guidelines could be used. Sequencing was done with the Illumina MiSeq system (500V2 kit).
Analysis of 16S next-generation sequencing data.
Bacteria from fecal samples taken right before gavage (T0) and 6 h post-gavage (T6) were sorted by FACS to enrich for transconjugants. The compositions of the sorted transconjugant and total populations for each sample were determined from 16S sequencing data via the UPARSE pipeline 27 (USEARCH version 10.0.240) to generate operational taxonomic unit (OTU) tables and abundances and the RDP Classifier 28 to assign the taxonomy. Phylogenetic associations were analyzed at the genus level with at least 90% confidence for 16S assignment. In all MiSeq runs, two blank controls with sterile water as input material were included to check for contaminants in the reagents and to filter out contaminant OTUs if present. Reads mapping to nonbacterial DNA (e.g., mitochondria, plastids, or other eukaryotic DNA) were also excluded from analysis. Only OTUs with more than ten reads were considered in downstream analysis.
Relative abundances of OTUs in unsorted total fecal populations were calculated as the normalized number of reads in a sample. Relative abundances of OTUs in T0 FACS-enriched populations were used to measure false positive background fluorescence, which was subtracted from the fluorescence of T6 transconjugant populations. The corrected relative abundance of each OTU in a T6 FACS-enriched population is given by the following formula:
where RA t i , ,sorted is the corrected relative abundance of OTU i at time t, A t i , is the normalized number of reads of OTU i at time t in the FACS-sorted sample, and N t is the fraction of GFP + mCherry -FACS-sorted events at time t. OTUs for which RA i 6, ,sorted is negative are eliminated from subsequent analysis, and all remaining RA i 6, ,sorted values are renormalized. The fold enrichment of each OTU in the FACS-sorted population is defined as its relative abundance in the FACS-sorted population divided by its relative abundance in the unsorted total population at T6. To overcome the problem of detection limits (i.e., OTU i appears in the sorted population but is present at levels below the detection limit in the total population), we added a pseudo-count of p to all relative abundances when calculating fold enrichments. p is given by
where n is the total number of reads in the FACS-sorted sample, and ⌊− ⌋ n log 10 is the floor function of (i.e., the greatest integer less than or equal to) − n log 10 . The fold enrichment of OTU i with the pseudo-count correction is calculated as
If the relative abundance of OTU i in the unsorted population is below the detection limit, then the fold enrichment is calculable as Whole-genome sequencing of engineered mouse gut bacteria isolates. To sequence MGB isolates, we prepared a sequencing library using the Nextera kit (Illumina) and used the Illumina HiSeq 2500 platform for 100-bp single-end reads. The SPAdes single-cell assembler pipeline (version 3.9.1) 29 was used to generate whole-genome contigs. BLAST and PlasmidFinder (version 1.3) 30 were used to analyze the sequences and identify native mobilization systems. Geneious (version 7.1.5) was used to visualize contig alignments to genomes and plasmids.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article. Supplementary Table 3 . Full plasmid maps, vectors, and strains used in this study are available from the corresponding author upon request or will be available on Addgene.
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Data collection
Flow cytometry was performed using InCyte 3.1 software on the Guava easyCyte HT flow cytometer. BD FACSDiva software was used for FACS on the BD FACSAria II cell sorter. NIS-Elements-AR software was used for fluorescence microscopy. Gen5 software was used to operate the plate reader for measurement of GFP expression in isolate strains.
Data analysis
All 16S data were processed using the UPARSE pipeline and the RDP classifier (USEARCH v.10.0.240) and subsequently analyzed in R, using the calculations stated in the Methods section. For whole genome sequencing assembly, we used SPAdes (v.3.9.1) software to generate contigs and then performed sequence analysis using BLAST, PlasmidFinder(v.1.3), and Geneious (v.7.1.5). FCS Express 6 was used for formatting FACS plots.
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Sample size
Sample sizes of mice were chosen to ensure that the effect of treatment with the engineered bacteria was robust and replicable. At least 3 mice were used for each treated group, and at least 2 mice were used for control groups.
Data exclusions No data were excluded from the analysis Replication All attempts at replication were successful. We ran multiple iterations of the study using different cohorts of mice, with multiple mice in each treatment group (see samples size above).
Randomization Mice were randomly allocated to different treatments. We ensured that animals shipped to the animal facility in different cages were mixed appropriately in order to avoid microbiome cage bias.
Blinding
Blinding does not apply to this study because the investigators needed to identify the cages of mice for subsequent FACS sorting and analysis.
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